Skip to main content
Signal8

Bristol James Arthur

SEC insider (Form 3/4/5 filer). CIK 0001715153. Director at Ernexa Therapeutics Inc. (ERNA) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Aug 31, 2026. Located in CAMBRIDGE, MA.

Companies Bristol James Arthur has filed insider reports for

  • Ernexa Therapeutics Inc. (ERNA): Director
  • Erasca, Inc. (ERAS): Director
Bristol James Arthur profile photo

Bristol James Arthur

CIK: 0001715153

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)7 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Ernexa Therapeutics Inc. logo
ERNA

Ernexa Therapeutics Inc.

Director
Erasca, Inc. logo
ERAS

Erasca, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Ernexa Therapeutics Inc. logo
    ERNA

    Ernexa Therapeutics Inc.

    Aug 31, 2026
    Award

    Stock Option (Right to buy)

    Direct
    8.3K shares-
  • Ernexa Therapeutics Inc. logo
    ERNA

    Ernexa Therapeutics Inc.

    Aug 31, 2026
    Award

    Stock Option (Right to buy)

    Direct
    5.1K shares-
  • Erasca, Inc. logo
    ERAS

    Erasca, Inc.

    Jun 26, 2026
    Award

    Stock option (right to buy)

    Direct
    29.9K shares-
  • Erasca, Inc. logo
    ERAS

    Erasca, Inc.

    Jan 1, 2026
    Award

    Stock Option (right to buy)

    Direct
    37.8K shares-
  • Erasca, Inc. logo
    ERAS

    Erasca, Inc.

    Jun 24, 2025
    Award

    Stock option (right to buy)

    Direct
    120K shares-
  • Eterna Therapeutics Inc. logo
    ERNA

    Eterna Therapeutics Inc.

    Feb 7, 2025
    Award

    Stock Option (Right to buy)

    Direct
    72.1K shares-
  • Erasca, Inc. logo
    ERAS

    Erasca, Inc.

    Jan 1, 2025
    Award

    Stock Option (right to buy)

    Direct
    45.7K shares-

1-7 of 7